BRIGHTER

Registered
Word Mark

Key Information

Serial Number

Registration Number

Status

Registered

Ownership

NA

Owner Name

Type: Organization / Corporation

Address

CH-4002 Basel
CH

Critical Dates

First Use Date

Not filed yet

Filing Date

Apr 1, 2025

Registration Date

Nov 18, 2025

Mark Descriptions

Services

Class 38
Provision of access to online forums for healthcare professionals and scientists to enhance collaboration and information exchange in the field of radioligand imaging and therapy research.
Class 41
Organization and hosting of conferences, congresses and symposia for healthcare professionals and scientists in the field of radioligand imaging and therapy; Educational services, namely the provision of seminars and non-downloadable webinars for healthcare professionals and scientists in the field of radioligand imaging and therapy.
Class 42
Hosting of non-downloadable online computer software platforms for healthcare professionals and scientists to enhance collaboration and information sharing in the field of radioligand imaging and therapy research.

Mark Elements

Text Mark
BRIGHTER
Category
Service Mark
Standard Characters
Yes
Color Claim
No
Data source: USPTO TSDR
View on USPTO website

Trademark Timeline

Filing Date

Apr 1, 2025

Publication Date

Sep 30, 2025

Registration Date

Nov 18, 2025

USPTO Records

TitleDateCategorySourcePagesFormatActions

AI AssessmentCached Mar 12, 2026, 05:57 AM
Cached

AI-generated analysis of USPTO data for this trademark. WARNING: Content may not be accurate or up to date. Validate all responses.

Trademark Summary

The standard character mark BRIGHTER is a service mark owned by Novartis AG of CH-4002 Basel, Switzerland, covering services in International Classes 038 (provision of access to online forums for healthcare professionals and scientists in radioligand imaging and therapy research), 041 (organization and hosting of conferences, symposia, seminars, and webinars for such professionals in the same field), and 042 (hosting non-downloadable software platforms for collaboration in radioligand imaging and therapy research). The mark is registered on the Principal Register (Reg. No. 8026754) effective November 18, 2025, with an expiration date of April 1, 2035, based on International Registration WO1869197 under Section 66A. No oppositions, legal proceedings, or other notable issues are present.

Recent Activity

This Madrid Protocol extension was notified in the US on August 7, 2025, approved for publication on August 27, 2025, and published for opposition on September 30, 2025. It proceeded to registration on November 18, 2025, with a final disposition notice created December 18, 2025.
USPTO
AI Analysis
v2.8.0
Generated Mar 12, 2026, 05:57 AM

Never miss important updates for this trademark

Get instant alerts when status changes, similar marks are filed, or renewal deadlines approach

Cookie Preferences

We use cookies (including Google Analytics) to improve our site and understand how visitors use it.